These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36424970)

  • 1. Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors.
    Hyassat D; Al-Saeksaek S; Naji D; Mahasneh A; Khader Y; Abujbara M; El-Khateeb M; Ajlouni K
    Front Public Health; 2022; 10():1002466. PubMed ID: 36424970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan.
    Abdel-Aal NM; Ahmad AT; Froelicher ES; Batieha AM; Hamza MM; Ajlouni KM
    Saudi Med J; 2008 Oct; 29(10):1423-8. PubMed ID: 18946566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study.
    Alami HE; Haddou I; Benaadi G; Lkhider M; Wakrim L; Allali M; Abidi O; Ghazal H; Idrissi NA; Nabih N; Naamane A; Maaroufi A; Khlil N; Hamdi S
    Pan Afr Med J; 2022; 43():86. PubMed ID: 36605985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes.
    Shahwan MJ; Jairoun AA; Farajallah A; Shanabli S
    Diabetes Metab Syndr; 2019; 13(4):2387-2392. PubMed ID: 31405648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
    Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
    J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Hypomagnesaemia among Obese Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG).
    Hyassat D; Al Sitri E; Batieha A; El-Khateeb M; Ajlouni K
    Int J Endocrinol Metab; 2014 Jul; 12(3):e17796. PubMed ID: 25237327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Pattern of Dyslipidemia and Its Associated Factors Among Patients with Type 2 Diabetes Mellitus in Jordan: A Cross-Sectional Study.
    Al Quran TM; Bataineh ZA; Al-Mistarehi AH; Zein Alaabdin AM; Allan H; Al Qura'an A; Weshah SM; Alanazi AA; Khader YS
    Int J Gen Med; 2022; 15():7669-7683. PubMed ID: 36217367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study.
    Li J; Nie Z; Ge Z; Shi L; Gao B; Yang Y
    Lipids Health Dis; 2022 Aug; 21(1):77. PubMed ID: 36002855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Determinants of Occurrence of Dyslipidemia in Subjects with Type 1 Diabetes Mellitus.
    Selvaraj M; Prasad HK; White S; Prasanna B; Sangaralingam T
    Indian J Pediatr; 2023 Feb; 90(2):118-123. PubMed ID: 35366198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus in two genetically distinct populations in Jordan. A Comparison between Arabs and Circassians/Chechens Living with Diabetes.
    Al-Eitan LN; Nassar AM; Dajani RB; Almomani BA; Saadeh NA
    Saudi Med J; 2017 Feb; 38(2):163-169. PubMed ID: 28133689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern and predictors of dyslipidemia in patients with type 2 diabetes mellitus.
    Karim MN; Ahmed KR; Bukht MS; Akter J; Chowdhury HA; Hossain S; Anwar N; Selim S; Chowdhury SH; Hossain F; Ali L
    Diabetes Metab Syndr; 2013; 7(2):95-100. PubMed ID: 23680249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study.
    Azar ST; Hantash HA; Jambart S; El-Zaheri MM; Rachoin R; Chalfoun A; Lahoud L; Okkeh O; Bramlage P; Brudi P; Ambegaonkar BM
    Vasc Health Risk Manag; 2014; 10():225-35. PubMed ID: 24872710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With the Development of Dyslipidemia Among Pediatric Patients With Diabetes: A Single-centre-based Study.
    Alshammri F; Geddie H; Sawalha N; Kim G; McAssey K; Morrison KM
    Can J Diabetes; 2023 Oct; 47(7):611-617. PubMed ID: 37392858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of dyslipidemia among Somali type 2 diabetic patients: a cross-sectional study.
    Alıcı G; Genç Ö
    Eur J Med Res; 2022 Nov; 27(1):253. PubMed ID: 36404351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of diabetes, hypertension, and dyslipidemia in Jordan: a cross-sectional study.
    Hyassat D; Abu Noor N; AlAjlouni Q; Jarrar Y; Qarajeh R; Mahasneh A; Elzoubi Z; Khader Y; Farahid O; El-Khateeb M; Ajlouni K
    Ann Med Surg (Lond); 2023 Mar; 85(3):439-445. PubMed ID: 37008178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum lipid profile in type 2 diabetes with and without adequate diabetes control in Sudanese population in north of Sudan.
    Awadalla H; Noor SK; Elmadhoun WM; Bushara SO; Almobarak AO; Sulaiman AA; Ahmed MH
    Diabetes Metab Syndr; 2018 Nov; 12(6):961-964. PubMed ID: 29954711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.
    Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle R; Sapkota RM; Sigdel T
    BMC Res Notes; 2017 Apr; 10(1):146. PubMed ID: 28376848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
    Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
    Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.